0001493152-26-034225.txt : 20260722 0001493152-26-034225.hdr.sgml : 20260722 20260722160019 ACCESSION NUMBER: 0001493152-26-034225 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260722 DATE AS OF CHANGE: 20260722 EFFECTIVENESS DATE: 20260722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc. CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591797 FILM NUMBER: 261193691 BUSINESS ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 FORMER COMPANY: FORMER CONFORMED NAME: MATEON THERAPEUTICS INC DATE OF NAME CHANGE: 20160613 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 D 1 primary_doc.xml X0708 D LIVE 0000908259 Oncotelic Therapeutics, Inc. 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 650-635-7000 DELAWARE MATEON THERAPEUTICS, INC. OXIGENE, INC. MATEON THERAPEUTICS INC OXIGENE INC Corporation true VUONG TRIEU 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer Director STEVEN KING 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Director ANTHONY MAIDA 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer Director SHAH AMIT 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer SEYMOUR FEIN 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer SARAN SAUND 29397 AGOURA ROAD SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 Executive Officer Biotechnology No Revenues 06b false 2026-07-10 true true true true false 0 N.A. None None None None None XX Unknown None CA CALIFORNIA CT CONNECTICUT OH OHIO true 711840 711840 0 RSUs, CONVERTIBLE INTO CONV. SERIES A PREF. SHARES, THEN INTO COMMON STOCK. GRANTED TO D&Os, EMPOYEES AND ADVISORS FOR SERVICES TO THE COMPANY. RSUs ARE CONTINGENT UPON ACHIEVEMENT OF CERTAIN CORPORATE MILESTONES true 33 33 0 0 RSUs, CONVERTIBLE INTO CONV. SERIES A PREF. SHARES, THEN INTO COMMON STOCK. GRANTED TO D&Os, EMPOYEES AND ADVISORS FOR SERVICES TO THE COMPANY. RSUs ARE CONTINGENT UPON ACHIEVEMENT OF CERTAIN CORPORATE MILESTONES 0 RSUs, CONVERTIBLE INTO CONV. SERIES A PREF. SHARES, THEN INTO COMMON STOCK. GRANTED TO D&Os, EMPOYEES AND ADVISORS FOR SERVICES TO THE COMPANY. RSUs ARE CONTINGENT UPON ACHIEVEMENT OF CERTAIN CORPORATE MILESTONES false Oncotelic Therapeutics, Inc. /s/ VUONG TRIEU VUONG TRIEU CEO 2026-07-22